Article Information
History
- April 20, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Lidya Handayani Tjan, MD, PhD,
- Koichi Furukawa, MD,
- Yukiya Kurahashi, MD,
- Silvia Sutandhio, MD,
- Mitsuhiro Nishimura, PhD,
- Jun Arii, DVM, PhD and
- Yasuko Mori, MD, PhD*
- Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan
- ↵*Corresponding author:
Prof. Yasuko Mori, Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine. 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo Japan, 650-0017, Tel: +81-78-382-6272; Fax: +81-78-382-6879, E-mail: ymori{at}med.kobe-u.ac.jp
Posted April 20, 2022.
High neutralizing activity against Omicron BA.2 can be induced by COVID-19 mRNA booster vaccination
